英国制药巨头阿斯利康与美国人工智能生物制药公司Absci近日签署了一项价值2.47亿美元的协议，共同研发抗癌药物。根据协议，Absci将利用其人工智能技术进行大规模蛋白质分析，以寻找可能的肿瘤疗法。阿斯利康一直致力于研究肿瘤疗法，此次合作将有助于加速研发进程。
英文翻译：
News title: AstraZeneca partners with Absci to develop cancer drug
Keywords: AstraZeneca, Absci, cancer drug
News content:
British pharmaceutical giant AstraZeneca has recently signed a $247 million deal with US artificial intelligence (AI) biopharmaceutical company Absci to co-develop cancer drugs. Under the agreement, Absci will utilize its AI technology for large-scale protein analysis to seek possible tumor therapies. AstraZeneca has been focusing on tumor therapy research, and this collaboration will help accelerate the development process.
【来源】https://www.ft.com/content/3d8a0ec6-5b04-486f-af2b-15de1486ffaf
Views: 1